The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study
Open accessAbstract
Importance: Positive associations between inflammatory biomarkers and risk of psychiatric disorders, including schizophrenia, have been reported in observational studies. However, conventional observational studies are prone to bias, such as reverse causation and residual confounding, thus limiting our understanding of the effect (if any) of inflammatory biomarkers on schizophrenia risk. Objective: To evaluate whether inflammatory biomarkers have an effect on the risk of developing schizophrenia. Design, Setting, and Participants: Two-sample mendelian randomization study using genetic variants associated with inflammatory biomarkers as instrumental variables to improve inference. Summary association results from large consortia of candidate gene or genome-wide association studies, including several epidemiologic studies with different designs, were used. Gene-inflammatory biomarker associations were estimated in pooled samples ranging from 1645 to more than 80 000 individuals, while gene-schizophrenia associations were estimated in more than 30 000 cases and more than 45 000 ancestry-matched controls. In most studies included in the consortia, participants were of European ancestry, and the prevalence of men was approximately 50%. All studies were conducted in adults, with a wide age range (18 to 80 years). Exposures: Genetically elevated circulating levels of C-reactive protein (CRP), interleukin-1 receptor antagonist (IL-1Ra), and soluble interleukin-6 receptor (sIL-6R). Main Outcomes and Measures: Risk of developing schizophrenia. Individuals with schizophrenia or schizoaffective disorders were included as cases. Given that many studies contributed to the analyses, different diagnostic procedures were used. Results: The pooled odds ratio estimate using 18 CRP genetic instruments was 0.90 (random effects 95% CI, 0.84-0.97; P = .005) per 2-fold increment in CRP levels; consistent results were obtained using different mendelian randomization methods and a more conservative set of instruments. The odds ratio for sIL-6R was 1.06 (95% CI, 1.01-1.12; P = .02) per 2-fold increment. Estimates for IL-1Ra were inconsistent among instruments, and pooled estimates were imprecise and centered on the null. Conclusions and Relevance: Under mendelian randomization assumptions, our findings suggest a protective effect of CRP and a risk-increasing effect of sIL-6R (potentially mediated at least in part by CRP) on schizophrenia risk. It is possible that such effects are a result of increased susceptibility to early life infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A significant causal association between C-reactive protein levels and schizophrenia
Inoshita, M., Numata, S., Tajima, A., Kinoshita, M., Umehara, H., Nakataki, M., Ikeda, M., Maruyama, S., Yamamori, H., Kanazawa, T., et al. (2016) · Scientific Reports · doi:10.1038/srep26105 · Cited by 43
RetractedVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
Self-citationBiological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Burgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
Self-citationA framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization
Bowden, J., Del Greco M, F., Minelli, C., Davey Smith, G., Sheehan, N., & Thompson, J. (2017) · Statistics in Medicine · doi:10.1002/sim.7221 · Cited by 1,887
Self-citationDetecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome
Greco M, F. D., Minelli, C., Sheehan, N. A., & Thompson, J. R. (2015) · Statistics in Medicine · doi:10.1002/sim.6522 · Cited by 1,700
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Bowden, J., Del Greco M., F., Minelli, C., Davey Smith, G., Sheehan, N. A., & Thompson, J. R. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw220 · Cited by 1,565
Self-citationImmune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116820 · Cited by 1,175
Burgess, S., Dudbridge, F., & Thompson, S. G. (2016) · Statistics in Medicine · doi:10.1002/sim.6835 · Cited by 1,153
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926
Hartwig, F. P., Davies, N. M., Hemani, G., & Davey Smith, G. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyx028 · Cited by 860
Self-citation(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) · BMJ · doi:10.1136/bmj.d548 · Cited by 642
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582
Smith, G. D., Lawlor, D. A., Harbord, R., Timpson, N., Day, I., & Ebrahim, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040352 · Cited by 569
Self-citationThe Global Costs of Schizophrenia
Knapp, M., Mangalore, R., & Simon, J. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007078 · Cited by 536
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C.-Y., Agerbo, E., & Mortensen, P. B. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.521 · Cited by 527
Dehghan, A., Dupuis, J., Barbalic, M., Bis, J. C., Eiriksdottir, G., Lu, C., Pellikka, N., Wallaschofski, H., Kettunen, J., Henneman, P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.948570 · Cited by 511
Khandaker, G. M., Zimbron, J., Lewis, G., & Jones, P. B. (2013) · Psychological Medicine · doi:10.1017/s0033291712000736 · Cited by 472
Fernandes, B. S., Steiner, J., Bernstein, H.-G., Dodd, S., Pasco, J. A., Dean, O. M., Nardin, P., Gonçalves, C.-A., & Berk, M. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.87 · Cited by 348
IL-6 biology: implications for clinical targeting in rheumatic disease
Calabrese, L. H., & Rose-John, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.127 · Cited by 328
Phillips, A. N., & Smith, G. D. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90155-3 · Cited by 275
Self-citationHughes, E., Bassi, S., Gilbody, S., Bland, M., & Martin, F. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00357-0 · Cited by 272
C-Reactive Protein Levels in Schizophrenia: A Review and Meta-Analysis
Miller, B. J., Culpepper, N., & Rapaport, M. H. (2014) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.micu.020813 · Cited by 267
Childhood infection and adult schizophrenia: A meta-analysis of population-based studies
Khandaker, G. M., Zimbron, J., Dalman, C., Lewis, G., & Jones, P. B. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.023 · Cited by 255
The meta-analysis of genome-wide association studies
Thompson, J. R., Attia, J., & Minelli, C. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr020 · Cited by 236
Prins, B. P., Abbasi, A., Wong, A., Vaez, A., Nolte, I., Franceschini, N., Stuart, P. E., Guterriez Achury, J., Mistry, V., Bradfield, J. P., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001976 · Cited by 199
Corbin, L. J., Richmond, R. C., Wade, K. H., Burgess, S., Bowden, J., Smith, G. D., & Timpson, N. J. (2016) · Diabetes · doi:10.2337/db16-0418 · Cited by 184
Self-citationSommer, I. E., de Witte, L., Begemann, M., & Kahn, R. S. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06823 · Cited by 182
IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose‐John, S., & Mittrücker, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 158
Challenges and novel approaches for investigating molecular mediation
Richmond, R. C., Hemani, G., Tilling, K. M., Smith, G. D., & Relton, C. L. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw197 · Cited by 156
† (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00034-0 · Cited by 141
Thomas, D. C., Lawlor, D. A., & Thompson, J. R. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2006.12.005 · Cited by 140
Davey Smith, G. (2011) · Genes & Nutrition · doi:10.1007/s12263-010-0181-y · Cited by 134
C-reactive protein at the interface between innate immunity and inflammation
Peisajovich, A., Marnell, L. L., Mold, C., & Clos, T. W. D. (2008) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.4.3.379 · Cited by 129
Lawlor, D. A., Richmond, R. C., Warrington, N. M., McMahon, G., Smith, G. D., Bowden, J., & Evans, D. M. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10567.1 · Cited by 126
Self-citationOkada, Y., Takahashi, A., Ohmiya, H., Kumasaka, N., Kamatani, Y., Hosono, N., Tsunoda, T., Matsuda, K., Tanaka, T., Kubo, M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq551 · Cited by 103
Wium‐Andersen, M. K., Ørsted, D. D., & Nordestgaard, B. G. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt120 · Cited by 100
Body mass index and psychiatric disorders: a Mendelian randomization study
Hartwig, F. P., Bowden, J., de Mola, C. L., Tovo‐Rodrigues, L., Smith, G. D., & Horta, B. L. (2016) · Scientific Reports · doi:10.1038/srep32730 · Cited by 86
Self-citationPleiotropy among Common Genetic Loci Identified for Cardiometabolic Disorders and C-Reactive Protein
Ligthart, S., de Vries, P. S., Uitterlinden, A. G., Albert Hofman, D., CHARGE Inflammation working group, Franco, O. H., Chasman, D. I., & Dehghan, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118859 · Cited by 55
Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults
Matteini, A. M., Li, J., Lange, E. M., Tanaka, T., Lange, L. A., Tracy, R. P., Wang, Y., Biggs, M. L., Arking, D. E., Fallin, M. D., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.10.002 · Cited by 53
Neonatal levels of acute phase proteins and later risk of non-affective psychosis
Gardner, R. M., Dalman, C., Wicks, S., Lee, B. K., & Karlsson, H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.5 · Cited by 48
Blomström, Å., Gardner, R. M., Dalman, C., Yolken, R. H., & Karlsson, H. (2015) · Translational Psychiatry · doi:10.1038/tp.2014.142 · Cited by 38
Kaspersen, K. A., Dinh, K. M., Erikstrup, L. T., Burgdorf, K. S., Pedersen, O. B., Sørensen, E., Petersen, M. S., Hjalgrim, H., Rostgaard, K., Nielsen, K. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164220 · Cited by 34
Zacho, J., Benfield, T., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.249680 · Cited by 22
Cited by
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Self-citationEvaluating the potential role of pleiotropy in Mendelian randomization studies
Hemani, G., Bowden, J., & Davey Smith, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy163 · Cited by 1,496
“By contrast, the (protective) apparent causal influence of CRP on schizophrenia is much more consistent between the CRP variant and all other instruments (71), indicating that whether a SNP exhibits horizontal pleiotropy is dependent on the causal question being asked (72,73) (Fig.”
BackgroundSelf-citationChoi, K. W., Chen, C.-Y., Stein, M. B., Klimentidis, Y. C., Wang, M.-J., Koenen, K. C., Smoller, J. W., & Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.4175 · Cited by 744
Using genetic data to strengthen causal inference in observational research
Pingault, J.-B., O’Reilly, P. F., Schoeler, T., Ploubidis, G. B., Rijsdijk, F., & Dudbridge, F. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0020-3 · Cited by 444
Ligthart, S., Vaez, A., Võsa, U., Stathopoulou, M. G., de Vries, P. S., Prins, B. P., Van der Most, P. J., Tanaka, T., Naderi, E., Rose, L. M., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.09.009 · Cited by 419
Self-citation
Metadata
- Authors
- Hartwig, F. P., Borges, M. C., Horta, B. L., Bowden, J., & Davey Smith, G.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2017-12-01
- Volume
- 74
- Issue
- 12
- Pages
- 1226
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2765391558
- Cited by
- 302
- References
- 56
- FWCI
- 15.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.